Juan Aponte-Ubillus is currently Scientist 2 from the Upstream–Drug Substance Technologies department at Biomarin Pharmaceutical Inc. He has over 7 years of experience characterizing and optimizing cell culture processes to produce complex biologics such as monoclonal antibodies and AAV vectors. Juan obtained his PhD degree from the Keck Graduate Institute of AppliedLife Sciences in California USA, and he is author of seven scientific publications in indexed journals and 2 international patent applications.

Talks

• Bioprocess Strategies to Mitigate the Impact of Proteases on Adeno-Associated Viral (AAV) Vector VP1 Capsid Content